Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

G-Plans vs Hims

G-Plans and Hims sell different medications; this is what separates them.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
G-Plans logo

G-Plans

4.1
★★☆☆☆2.1/5

Best for: coaching bundled into the price rather than sold separately

Visit G-Plans →
VS
Hims logo

Hims

6.8
★★★☆☆3.4/5

Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC

Visit Hims →

If you are choosing between G-Plans and Hims, price alone will not settle it. Hims leads our six-part score, 6.8 to 4.1. One of the two has an FDA warning letter on record, covered below.

G-Plans vs Hims price

Hims publishes $199 a month. G-Plans does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.

Medications and formats

Hims lists semaglutide and tirzepatide; G-Plans does not name its drug.

On format, G-Plans posts no priced format, while Hims prices compounded injections and brand-name pens.

If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.

Where each one treats patients

G-Plans does not publish where it ships, and Hims lists 50 states.

Pricing

G-Plans

Pricing not publicly listed.

Hims

StartingCompounded
$199/mo
semaglutide
StartingBrand-name
$299/mo
tirzepatide

Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)

What each price covers

Both prices cover the medication itself.

G-Plans' price also covers the clinician visit and coaching, which Hims does not claim.

G-Plans is silent on shipping and lab work.

Hims is silent on shipping and lab work.

G-Plans

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

In the price

Hims

Covered by the monthly price

Medication

In the price

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Not stated

Coaching

Charged on top

Where each one scores higher

Overall, Hims scores 6.8 and G-Plans 4.1 out of 10.

G-Plans is stronger on support (5.0 vs 3.0).

Hims is stronger on effectiveness (10.0 vs 5.0), user experience (8.0 vs 3.0), trust & safety (7.0 vs 4.0) and accessibility (10.0 vs 5.0).

Value is within half a point.

How we score

G-Plans

4.1/10

Overall

Hims

6.8/10

Value25%

3.0A
vs
B
3.0

Effectiveness25%

5.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

4.0A
vs
B
7.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

5.0A
vs
B
3.0

FDA warning letters

The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.

G-Plans has no FDA warning letter on record with us.

Features & Coverage

FeatureG-PlansHims
Starting PriceNot published$199/mo
Features2 features2 features
States AvailableNot disclosed50
Compounded—✓ Yes
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA Warning Letters✓None1 letter

About G-Plans

G-Plans is a personalized nutrition and weight loss program. GLP-1 medication is an optional add-on.

Read our full G-Plans review →

About Hims

Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.

Read our full Hims review →

Pros & Cons

G-Plans

What we like

  • The monthly price includes the medication, clinician visits and coaching
  • We found no FDA warning letters issued to G-Plans

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Hims

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication
  • Serves all 50 states
  • Names 4 pharmacies that fill its prescriptions, which most sellers do not

Watch-outs

  • Not included in the monthly price: clinician visits, coaching
  • The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Hims

Hims wins this one, 6.8 to 4.1, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC. G-Plans fits better if coaching bundled into the price rather than sold separately is your priority.

Choose G-Plans if…

You want coaching bundled into the price rather than sold separately.

Choose Hims if…

You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.6

Luvo Health

Moving between compounded and brand without changing seller

8.4

Strut Health

Semaglutide at $99/month, 48% below the typical price

8.4

Enhance MD

Knowing which pharmacy fills the vial: it names Tru Meds Rx

G-Plans vs Hims: FAQ

Only Hims publishes a price ($199 a month). G-Plans quotes after sign-up.
No. G-Plans lists no named drug; Hims lists semaglutide and tirzepatide.
G-Plans does not publish where it ships; Hims lists 50 states. Confirm your state before paying.
Both include the medication itself. Only G-Plans includes the clinician visit and coaching.
G-Plans has none. Hims has an open FDA warning letter from September 9, 2025.
No. Neither G-Plans nor Hims pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.